Daniel Fineberg
Impact in
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
-
- Advanced Glycation End Products research
Papers in
- Surgery 2
- Bariatric Surgery and Outcomes 2
- Esophageal and GI Pathology 1
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Karin Jandeleit‐Dahm (1 shared paper)Mark E. Cooper (1 shared paper)Justin A. Mariani (1 shared paper)Kathryn Mackie (1 shared paper)Olga Vujovic (1 shared paper)Alison Duncan (1 shared paper)Wendy A. Brown (2 shared papers)Paul R. Burton (1 shared paper)
In The Last Decade
Daniel Fineberg
8 papers receiving 256 citations
Peers
Comparison fields: 5 of 68
- Nephrology 84
- Clinical Biochemistry 26
- Endocrinology, Diabetes and Metabolism 52
- Cancer Research 34
- Family Practice 4
Countries citing papers authored by Daniel Fineberg
This map shows the geographic impact of Daniel Fineberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Fineberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Fineberg more than expected).
Fields of papers citing papers by Daniel Fineberg
This network shows the impact of papers produced by Daniel Fineberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Fineberg. The network helps show where Daniel Fineberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Fineberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 229 | |
| 2 | 2020 | 12 | |
| 3 | 2020 | 6 | |
| 4 | 2022 | 4 | |
| 5 | 2023 | 3 | |
| 6 | 2021 | 3 | |
| 7 | 2019 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2025 | 0 |
About Daniel Fineberg
Daniel Fineberg is a scholar working on Surgery, Neurology, Epidemiology, Pharmacy and Endocrinology, Diabetes and Metabolism, having authored 9 papers that have together received 261 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (2 papers), Obesity and Health Practices (2 papers), Diabetes Treatment and Management (2 papers), Bariatric Surgery and Outcomes (2 papers), Child Nutrition and Feeding Issues (1 paper), Diabetes Management and Research (1 paper), Esophageal and GI Pathology (1 paper) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Nephrology (84 citations), Clinical Biochemistry (26 citations), Endocrinology, Diabetes and Metabolism (52 citations), Cancer Research (34 citations) and Family Practice (4 citations). Daniel Fineberg has collaborated with scholars based in Australia, India and Belarus. Frequent co-authors include Karin Jandeleit‐Dahm, Mark E. Cooper, Justin A. Mariani, Kathryn Mackie, Olga Vujovic, Alison Duncan, Wendy A. Brown, Paul R. Burton, Mariana Hoffman and Michelle H. Lim. Their work appears in journals such as The Medical Journal of Australia, ANZ Journal of Surgery, Frontiers in Public Health, Obesity Surgery and Journal of Pharmacy Practice and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.